Dipexium Pharmaceut (DPRX) Misses Q3 EPS by 2c

Dipexium Pharmaceut (NASDAQ: DPRX) reported Q3 EPS of ($0.49), $0.02 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Dipexium Pharmaceut (DPRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c